What the technology does
A ligand trap that specifically blocks Ang-2 activity
A highly specific ligand trap for Ang2, evolved using a proprietary directed evolution technique, that does not block the protective activity of Ang1.
Main application field
Treatment of pathological angiogenesis, e.g. diabetic retinopathy.
Technology ready for evaluation and collaborative development2
Priority UK filing made 20/12/2012. PCT/GB2013/053392
Exclusive or non-exclusive licence